BRPI0710959A2 - Uso de uma proteína anti-secretória e peptídeo - Google Patents
Uso de uma proteína anti-secretória e peptídeo Download PDFInfo
- Publication number
- BRPI0710959A2 BRPI0710959A2 BRPI0710959-8A BRPI0710959A BRPI0710959A2 BR PI0710959 A2 BRPI0710959 A2 BR PI0710959A2 BR PI0710959 A BRPI0710959 A BR PI0710959A BR PI0710959 A2 BRPI0710959 A2 BR PI0710959A2
- Authority
- BR
- Brazil
- Prior art keywords
- antisecretory
- secretary
- peptide protein
- prevention
- pharmaceutical compositions
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 102000004169 proteins and genes Human genes 0.000 title abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 230000001262 anti-secretory effect Effects 0.000 abstract 4
- 206010020772 Hypertension Diseases 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 230000002265 prevention Effects 0.000 abstract 2
- 210000001124 body fluid Anatomy 0.000 abstract 1
- 239000010839 body fluid Substances 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Dispersion Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Abstract
USO DE UMA PROTEìNA ANTI-SECRETóRIA E PEPTìDEO. A presente invenção refere-se ao uso de fatores anti-secretários, tal como proteínas anti-secretárias, ou homólogos, derivados e/ou fragmentos da mesma com atividade anti-secretária, para a fabricação de composições farmacêuticas para o uso no tratamento e/ou prevenção da hipertensão intra-ocular. A invenção refere-se, portanto, ao uso de composições farmacêuticas contendo fatores anti-secretórios na prevenção e/ou tratamento da hipertensão intra-ocular, a qual se caracteriza principalmente pela obstrução do efluxo de fluido corporal, resultando na elevação da pressão no olho. A invenção se presta a uma nova abordagem para o tratamento e/ou prevenção de tal condição, reduzindo a pressão a níveis aceitáveis, opcionalmente de 21 mm Hg ou menos.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0600932-8 | 2006-04-27 | ||
| SE0600932 | 2006-04-27 | ||
| PCT/SE2007/000414 WO2007126364A2 (en) | 2006-04-27 | 2007-04-27 | Use of antisecretory factors for treating intraocular hypertension |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BRPI0710959A2 true BRPI0710959A2 (pt) | 2012-02-28 |
| BRPI0710959B1 BRPI0710959B1 (pt) | 2018-11-06 |
| BRPI0710959B8 BRPI0710959B8 (pt) | 2021-05-25 |
Family
ID=38561776
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0710959A BRPI0710959B8 (pt) | 2006-04-27 | 2007-04-27 | uso de uma proteína anti-secretória ou fragmentos da mesma para a fabricação de uma composição farmacêutica para a prevenção ou tratamento da hipertensão intra-ocular. |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US8207296B2 (pt) |
| EP (2) | EP2015767B1 (pt) |
| JP (2) | JP5284948B2 (pt) |
| KR (1) | KR20090040404A (pt) |
| CN (2) | CN102633863B (pt) |
| AU (1) | AU2007244004B2 (pt) |
| BR (1) | BRPI0710959B8 (pt) |
| CA (2) | CA2771087C (pt) |
| DK (2) | DK2015767T3 (pt) |
| ES (2) | ES2561945T3 (pt) |
| IL (1) | IL194773A (pt) |
| MX (1) | MX2008013769A (pt) |
| NZ (2) | NZ572255A (pt) |
| PL (2) | PL2015767T3 (pt) |
| RU (1) | RU2458703C2 (pt) |
| SG (1) | SG171602A1 (pt) |
| WO (1) | WO2007126364A2 (pt) |
| ZA (1) | ZA200809115B (pt) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2015767T3 (pl) * | 2006-04-27 | 2016-05-31 | Lantmaennen As Faktor Ab | Zastosowanie czynnika przeciwwydzielniczego do leczenia nadciśnienia śródgałkowego |
| US9962424B2 (en) | 2007-04-27 | 2018-05-08 | Lantmännen As-Faktor Ab | Use of antisecretory factors (AF) for optimizing cellular uptake |
| EP3769778A1 (en) | 2009-02-11 | 2021-01-27 | Lantmännen Medical AB | Use of antisecretory factors (af) for optimizing cellular uptake |
| WO2013050795A1 (en) * | 2011-10-03 | 2013-04-11 | Femtonics Kft. | Use of photoactive compounds |
| US20190192622A1 (en) * | 2012-12-20 | 2019-06-27 | Lantmännen As-Faktor Ab | Use of Antisecretory Factor (AF) in Glioblastoma Treatment |
| WO2017009004A1 (en) * | 2015-07-10 | 2017-01-19 | Lantmännen As-Faktor Ab | Process for producing egg yolk with high content of af-16 |
| WO2018015379A1 (en) | 2016-07-18 | 2018-01-25 | Lantmännen As-Faktor Ab | Antisecretory factor 17 |
| US12582697B2 (en) | 2018-06-28 | 2026-03-24 | Lantmännen Medical Ab | Antisecretory factor for use in treatment and/or prevention of acute respiratory failure |
| WO2020065089A2 (en) | 2018-09-28 | 2020-04-02 | Lantmännen Functional Foods Ab | A consumable product comprising malted dehulled oat |
| WO2020065091A1 (en) | 2018-09-28 | 2020-04-02 | Lantmännen Functional Foods Ab | A consumable product comprising malted wheat |
| US20230096303A1 (en) | 2020-03-26 | 2023-03-30 | Lantmännen Functional Foods Ab | A Consumable Product Comprising Malted Cereals for Promoting Recovery at Physical Activity |
| US20240148709A1 (en) * | 2022-11-08 | 2024-05-09 | Aisa Pharma, Inc. | Methods of treating eye pain and eye disorders |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH682716A5 (de) | 1992-01-13 | 1993-11-15 | Christian Fricker | Benzo-Pyrone und/oder Dobesilat-Calcium enthaltende pharmazeutische Zusammensetzung. |
| US5585401A (en) * | 1994-12-09 | 1996-12-17 | The Reents Of The University Of California | Method for enhancing outflow of aqueous humor in treatment of glaucoma |
| SE508609C2 (sv) | 1995-08-24 | 1998-10-19 | Rural Patent Svenska Ab | Antisekretorisk faktor - dess aminosyrasekvens, nubleinsyrasekvens och användning |
| JP2000506375A (ja) * | 1996-01-26 | 2000-05-30 | エイチエスシー リサーチ アンド デベロップメント リミテッド パートナーシップ | アルツハイマー病に関連する核酸およびタンパク質、ならびにその使用 |
| SE9604251L (sv) | 1996-11-20 | 1997-12-22 | Svenska Lantmaennen Riksfoerbu | Födoämne som vid förtäring inducerar antisekretoriska proteiner |
| SE513496C2 (sv) | 1998-12-17 | 2000-09-18 | Rural Patent Svenska Ab | NASP-berikad äggula samt dess användning |
| WO2001005968A1 (en) * | 1999-06-21 | 2001-01-25 | Inkine Pharmaceutical Company, Inc. | Angiocidin: a cys-ser-val-thr-cys-gly specific tumor cell adhesion receptor |
| RU2192898C1 (ru) * | 2001-08-16 | 2002-11-20 | Московский научно-исследовательский институт глазных болезней им. Гельмгольца | Способ лечения герпетического кератита с изъязвлением |
| GB0322645D0 (en) * | 2003-09-26 | 2003-10-29 | Melacure Therapeutics Ab | Use of antisecretory factor peptides |
| ES2472737T3 (es) * | 2006-04-27 | 2014-07-02 | Lantmnnen As-Faktor Ab | Usos m�dicos adicionales de la proteína antisecretora |
| EP2037950B1 (en) * | 2006-04-27 | 2014-04-23 | Lantmännen AS-Faktor AB | Further medical uses of antisecretory protein |
| PL2015767T3 (pl) * | 2006-04-27 | 2016-05-31 | Lantmaennen As Faktor Ab | Zastosowanie czynnika przeciwwydzielniczego do leczenia nadciśnienia śródgałkowego |
-
2007
- 2007-04-27 PL PL07748079T patent/PL2015767T3/pl unknown
- 2007-04-27 RU RU2008146733/15A patent/RU2458703C2/ru active
- 2007-04-27 MX MX2008013769A patent/MX2008013769A/es active IP Right Grant
- 2007-04-27 CA CA2771087A patent/CA2771087C/en not_active Expired - Fee Related
- 2007-04-27 ES ES07748079.6T patent/ES2561945T3/es active Active
- 2007-04-27 NZ NZ572255A patent/NZ572255A/en not_active IP Right Cessation
- 2007-04-27 DK DK07748079.6T patent/DK2015767T3/en active
- 2007-04-27 JP JP2009507632A patent/JP5284948B2/ja not_active Expired - Fee Related
- 2007-04-27 CA CA2650344A patent/CA2650344C/en not_active Expired - Fee Related
- 2007-04-27 SG SG201102876-8A patent/SG171602A1/en unknown
- 2007-04-27 WO PCT/SE2007/000414 patent/WO2007126364A2/en not_active Ceased
- 2007-04-27 PL PL12157100T patent/PL2468292T3/pl unknown
- 2007-04-27 ES ES12157100T patent/ES2773945T3/es active Active
- 2007-04-27 BR BRPI0710959A patent/BRPI0710959B8/pt not_active IP Right Cessation
- 2007-04-27 CN CN201210058790.XA patent/CN102633863B/zh not_active Expired - Fee Related
- 2007-04-27 EP EP07748079.6A patent/EP2015767B1/en not_active Not-in-force
- 2007-04-27 DK DK12157100.4T patent/DK2468292T3/da active
- 2007-04-27 NZ NZ598426A patent/NZ598426A/xx not_active IP Right Cessation
- 2007-04-27 CN CN200780014996.XA patent/CN101432013B/zh not_active Expired - Fee Related
- 2007-04-27 AU AU2007244004A patent/AU2007244004B2/en not_active Ceased
- 2007-04-27 KR KR1020087029053A patent/KR20090040404A/ko not_active Ceased
- 2007-04-27 EP EP12157100.4A patent/EP2468292B8/en active Active
-
2008
- 2008-10-22 IL IL194773A patent/IL194773A/en active IP Right Grant
- 2008-10-23 ZA ZA200809115A patent/ZA200809115B/xx unknown
- 2008-10-27 US US12/289,388 patent/US8207296B2/en not_active Expired - Fee Related
-
2012
- 2012-03-05 JP JP2012047547A patent/JP2012153695A/ja active Pending
- 2012-05-11 US US13/469,838 patent/US9000125B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0710959A2 (pt) | Uso de uma proteína anti-secretória e peptídeo | |
| BRPI0519508A2 (pt) | análogos de aminopirazina para tratamento de glaucoma e outras doenças ou condições mediadas por rho cinase | |
| WO2007104541A3 (en) | Compositions and methods using serine protease inhibiting peptides for treating ophthalmic disorders | |
| MX2009007065A (es) | Variantes de desintegrina y usos farmaceuticos de los mismos. | |
| EA201071413A1 (ru) | Способ и композиция для лечения повышения внутриглазного давления и глаукомы | |
| GEP20084520B (en) | Use of retinyl derivatives and compositions thereof for treating ophthalmic diseases | |
| BRPI0210886B8 (pt) | composto, composição farmacêutica, uso de um composto, e, métodos de geração de imagens, de monitoração do efeito do tratamento de um corpo humano ou animal com uma droga para combater uma condição associada com câncer e de tratamento de câncer ou de uma doença relacionada em um corpo humano ou animal | |
| BRPI0607447A2 (pt) | solução oftálmica de bimatoprost aprimorada | |
| ATE359794T1 (de) | 3, 7 thiaprostansäurederivate als mittel zur verminderung des augeninnendruckes | |
| ATE500826T1 (de) | Verwendung von azabicyclohexan-derivaten | |
| BR112012015188A8 (pt) | composição e método para o tratamento e/ou a prevenção de uma doença ocular relacionada à angiogênese | |
| MY146920A (en) | Aminothiazole derivatives and their uses as antibacterial agents | |
| ATE508711T1 (de) | Vorgeformter intrastromaler hornhauteinsatz für hornhautanomalien oder -dystrophien | |
| BR0210238A (pt) | Novos análogos de aril-amino-propano e seu uso para o tratamento de glaucoma | |
| Glibowicka et al. | Enhanced proteolytic resistance of cationic antimicrobial peptides through lysine side chain analogs and cyclization | |
| WO2007054257A3 (en) | Indene derivatives, their preparation and use as medicaments | |
| IL267555A (en) | Ostraulicin, a functionally related variette, an extract containing ostraulicin and its uses | |
| AU2017334047A1 (en) | Therapeutic protein | |
| BR0314419A (pt) | Compostos de 5-croman-5-il-etilamina substituìdos, seu uso e composição farmacêutica incluindo-o | |
| EA200601238A1 (ru) | Медикаменты для профилактики и лечения бромидроза и для улучшения запаха тела | |
| JP2018507259A (ja) | 抗微生物ペプチド | |
| ATE480552T1 (de) | Stq-peptide | |
| BR112022019403A2 (pt) | Uso de um derivado de tienopiridona no tratamento de doença renal policística autossômica dominante (drpad) | |
| WO2006074452A3 (en) | Regulation of ccn2 by ccn3 and its therapeutic and diagnostic potential in fibrosis, sclerosis and other diseases | |
| BRPI0517972A (pt) | ácido 5,6,7-triidroxiheptanóico e análogos para o tratamento de doenças oculares e doenças associadas com respostas hiperproliferativas e angiogênicas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 06/11/2018, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 27/04/2007 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 15A ANUIDADE. |
|
| B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2668 DE 22-02-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |